The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 06, 2020

Filed:

Jan. 19, 2018
Applicant:

Infectious Disease Research Institute, Seattle, WA (US);

Inventors:

Steven G. Reed, Bellevue, WA (US);

Darrick Carter, Seattle, WA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/39 (2006.01); A61K 9/107 (2006.01); A61K 39/00 (2006.01); A61K 39/35 (2006.01); A61K 45/06 (2006.01); A61K 39/008 (2006.01); A61K 39/04 (2006.01); A61K 39/145 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/107 (2013.01); A61K 39/008 (2013.01); A61K 39/0011 (2013.01); A61K 39/04 (2013.01); A61K 39/145 (2013.01); A61K 39/35 (2013.01); A61K 45/06 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55572 (2013.01); Y02A 50/386 (2018.01); Y02A 50/388 (2018.01); Y02A 50/39 (2018.01); Y02A 50/396 (2018.01); Y02A 50/41 (2018.01); Y02A 50/491 (2018.01);
Abstract

Compositions and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed based on the discovery of useful immunological adjuvant properties in a synthetic, glycopyranosyl lipid adjuvant (GLA) that is provided in substantially homogeneous form. Chemically defined, synthetic GLA offers a consistent vaccine component from lot to lot without the fluctuations in contaminants or activity that compromise natural-product adjuvants. Also provided are vaccines and pharmaceutical compositions that include GLA and one or more of an antigen, a Toll-like receptor (TLR) agonist, a co-adjuvant and a carrier such as a pharmaceutical carrier.


Find Patent Forward Citations

Loading…